MANINI, MATTEO ANGELO
 Distribuzione geografica
Continente #
EU - Europa 2.136
NA - Nord America 1.675
AS - Asia 1.391
SA - Sud America 110
AF - Africa 29
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.352
Nazione #
US - Stati Uniti d'America 1.605
GB - Regno Unito 972
CN - Cina 442
SG - Singapore 336
DE - Germania 270
IT - Italia 255
SE - Svezia 162
HK - Hong Kong 144
BD - Bangladesh 128
VN - Vietnam 124
RU - Federazione Russa 112
FR - Francia 87
BR - Brasile 75
IN - India 68
UA - Ucraina 64
CA - Canada 54
IE - Irlanda 44
NL - Olanda 40
FI - Finlandia 39
KR - Corea 37
TR - Turchia 35
EU - Europa 23
DK - Danimarca 21
ID - Indonesia 20
CO - Colombia 17
CI - Costa d'Avorio 16
JP - Giappone 15
BE - Belgio 12
AR - Argentina 10
GR - Grecia 10
ES - Italia 9
MX - Messico 8
UZ - Uzbekistan 8
AU - Australia 7
CH - Svizzera 7
PL - Polonia 7
IQ - Iraq 6
AT - Austria 5
PK - Pakistan 5
RO - Romania 5
CL - Cile 4
CZ - Repubblica Ceca 3
MA - Marocco 3
PH - Filippine 3
SA - Arabia Saudita 3
SI - Slovenia 3
ZA - Sudafrica 3
CR - Costa Rica 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 5.371
Città #
Southend 921
Singapore 179
Ashburn 165
Dallas 163
Chandler 144
Hong Kong 130
Beijing 110
Frankfurt am Main 91
San Jose 78
Milan 67
Seattle 61
New York 58
Santa Clara 53
Princeton 51
Ann Arbor 49
Dublin 44
Wilmington 44
Jacksonville 43
Dearborn 40
Council Bluffs 33
Fairfield 32
Hanoi 32
Ho Chi Minh City 31
Los Angeles 30
Houston 28
Toronto 28
Grafing 27
Nanjing 27
Buffalo 26
Moscow 25
Shanghai 25
Bengaluru 23
Lauterbourg 23
Woodbridge 23
Des Moines 22
Redmond 21
Helsinki 20
Boardman 19
Mountain View 19
Guangzhou 18
Serra 17
Abidjan 16
Columbus 15
Rome 15
Bogotá 14
Munich 14
Andover 13
Redwood City 13
Brussels 12
Cambridge 12
Saint Petersburg 11
Sakarya 11
Phoenix 10
Hefei 9
Tokyo 9
Turin 9
Da Nang 8
Hangzhou 8
Jakarta 8
Somerville 8
Atlanta 7
Berlin 7
Bitonto 7
Fuzhou 7
Haiphong 7
Jersey City 7
Nanchang 7
Quanzhou 7
Changsha 6
Hebei 6
Jinan 6
Naples 6
São Paulo 6
Athens 5
Cangzhou 5
Central District 5
Dong Ket 5
Istanbul 5
Jiaxing 5
Kunming 5
London 5
Mumbai 5
San Diego 5
Wuhan 5
Bari 4
Bologna 4
Brooklyn 4
Montreal 4
Ottawa 4
Piscataway 4
Shenyang 4
Shenzhen 4
Sunnyvale 4
The Dalles 4
Warsaw 4
Auburn Hills 3
Baghdad 3
Boston 3
Bühl 3
Caserta 3
Totale 3.455
Nome #
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation 613
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation 374
Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men 280
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation 267
Serum expression of lectin reactive alphafetoprotein, des-gamma-carboxy prothrombin, Golgi protein-73 antigen and antibody, for the diagnosis of hepatocellular carcinoma 248
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis 248
Management of Biliary Anastomotic Strictures After Liver Transplantation (BASALT Study): a Nationwide Italian Survey 238
TACE with drug-eluting beads is effective for the maintenance of the milan-in status in patients with a small hepatocellular carcinoma 235
Recist versus easl criteria for the evaluation of HCC response to sorafenib 215
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 209
The impact of infection by multidrug resistant agents in patients with cirrhosis : A multicenter prospective study 206
Characterisation of liver nodules in patients with chronic liver disease by MRI: comparison between the LI-RADS v2014 and the Likert scale 203
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 202
Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS v.2018) scale and its comparison with the Likert scale 201
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis 197
Prospective validation of immunohistological stain for glypican-3 (GPC-3) in the early diagnosis of hepatocellular carcinoma 187
Chemoembolization with epirubicin drug eluting beads to treat early and intermediate hepatocellular carcinoma 185
The natural history of hepatic macroregenerative nodules developing in cirrhotic patients during surveillance with ultrasound (US) 170
The natural history of macroregenerative nodules prospectively detected in cirrhotic patients under surveillance 166
Prospective validation of AASLD guidelines for the early diagnosis of hepatocellular carcinoma in cirrhotic patients 164
Prospective validation of immunohistological stain for glypican-3 (GPC-3) in the early diagnosis of hepatocellular carcinoma 163
Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients 156
Prospective evaluation of staging systems for hepatocellular carcinoma detected during surveillance of cirrhotic patients 152
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients : a 5-year follow-up study after hepatitis B immunoglobulin withdrawal 151
Prospective validation of AASLD guidelines for the early diagnosis of hepatocellular carcinoma in cirrhotic patients 146
Totale 5.576
Categoria #
all - tutte 13.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.814


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022389 40 23 13 39 17 10 23 41 47 55 13 68
2022/2023455 57 62 44 42 46 99 6 26 49 2 18 4
2023/2024322 14 21 21 11 95 9 25 35 18 12 34 27
2024/2025659 32 80 14 69 27 23 17 79 34 78 55 151
2025/20261.545 148 83 206 93 136 81 199 60 99 94 203 143
Totale 5.576